Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers von Arora, Mansi, Bogenberger, James M., Abdelrahman, Amro M., Yonkus, Jennifer, Alva‐Ruiz, Roberto, Leiting, Jennifer L., Chen, Xianfeng, Serrano Uson Junior, Pedro Luiz, Dumbauld, Chelsae R., Baker, Alexander T., Gamb, Scott I., Egan, Jan B., Zhou, Yumei, Nagalo, Bolni Marius, Meurice, Nathalie, Eskelinen, Eeva‐Liisa, Salomao, Marcela A., Kosiorek, Heidi E., Braggio, Esteban, Barrett, Michael T., Buetow, Kenneth H., Sonbol, Mohamad B., Mansfield, Aaron S., Roberts, Lewis R., Bekaii‐Saab, Tanios S., Ahn, Daniel H., Truty, Mark J., Borad, Mitesh J.

Volltext

Characterizing oncolytic potential and safety of a G-protein pseudotyped vesiculovirus in sarcoma von Dumbauld, Chelsae R, Seetharam, Mahesh, Nagalo, Bolni Marius, Borad, Mitesh

Volltext

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy von Zhang, Yuguo, Gabere, Musa, Taylor, Mika A, Simoes, Camila C, Dumbauld, Chelsae, Barro, Oumar, Tesfay, Mulu Z, Graham, Alicia L, Ferdous, Khandoker Usran, Savenka, Alena V, Chamcheu, Jean Christopher, Washam, Charity L, Alkam, Duah, Gies, Allen, Byrum, Stephanie D, Conti, Matteo, Post, Steven R, Kelly, Thomas, Borad, Mitesh J, Cannon, Martin J, Basnakian, Alexei, Nagalo, Bolni M

Volltext

Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers von Nagalo, Bolni Marius, Zhou, Yumei, Loeuillard, Emilien J, Dumbauld, Chelsae, Barro, Oumar, Elliott, Natalie M, Baker, Alexander T, Arora, Mansi, Bogenberger, James M, Meurice, Nathalie, Petit, Joachim, Uson, Jr, Pedro Luiz Serrano, Aslam, Faaiq, Raupach, Elizabeth, Gabere, Musa, Basnakian, Alexei, Simoes, Camila C, Cannon, Martin J, Post, Steven R, Buetow, Kenneth, Chamcheu, Jean Christopher, Barrett, Michael T, Duda, Dan G, Jacobs, Bertram, Vile, Richard, Barry, Michael A, Roberts, Lewis R, Ilyas, Sumera, Borad, Mitesh J

Volltext

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations von Uson Junior, Pedro Luiz Serrano, DeLeon, Thomas T., Bogenberger, James M., Pai, Rish K., Kosiorek, Heidi E., Yin, Jun, Ahn, Daniel H., Sonbol, Mohammad Bassam, Bekaii-Saab, Tanios, Mansfield, Aaron S., Buetow, Kenneth, Gores, Gregory J., Smoot, Rory, Vasmatzis, George, Kipp, Benjamin R., Mahipal, Amit, Baker, Alexander T., Babiker, Hani, Barro, Oumar, Dumbauld, Chelsae, Zhou, Yumei, Aslam, Faaiq N., Barrett, Michael, Jacobs, Bertram, Meurice, Nathalie, Arora, Mansi, Petit, Joachim, Elliott, Natalie, Nagalo, Bolni, Salomao, Marcela A., Borad, Mitesh J.

Volltext